AbbVie Inc. (ABBV) Capital expenditures 2016–2025
AbbVie Inc. (ABBV) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.2BFY2025 · since FY2016: $479.0M → $1.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.2B | +24.6% |
| FY2024 | $974.0M | +25.4% |
| FY2023 | $777.0M | +11.8% |
| FY2022 | $695.0M | -11.7% |
| FY2021 | $787.0M | -1.4% |
| FY2020 | $798.0M | +44.6% |
| FY2019 | $552.0M | -13.5% |
| FY2018 | $638.0M | +20.6% |
| FY2017 | $529.0M | +10.4% |
| FY2016 | $479.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice